BLOG
Life Sciences


How Artificial Intelligence is impacting life sciences

Written by Elvis Paćelat in Life Sciences on 20/09/17


Artificial Intelligence (AI) is one of the most talked-about technologies of the last decade. It saw more deployment initially in other industries – telecoms and financial services (FS) were amongst the early adopters - but the past few years have seen a number of life sciences firms embrace AI and reap some of the benefits.

Read more

Regulatory transformation: cloud reality check

Written by Siniša Belina in Life Sciences on 19/10/16


An industry debate at AMPLEXOR’s annual user conference in June examined the role of cloud services in driving the next generation of regulatory information management in life sciences, and I want to share with you the main points of the discussion.

The need for regulatory information management (RIM) transformation is driving new interest in cloud services, particularly access to the latest applications via Software as a Service (SaaS) delivery models. But there are different approaches to the cloud, and data sensitivities to consider, so it is rarely a straightforward decision.

It was in this context that AMPLEXOR recently hosted a major industry panel debate, keen to sort the fact from the fiction and establish some best-practice approaches to cloud-based service use in life sciences. The discussion, chaired by Steve Scribner of consultancy The Scribner Group, brought together heavyweight regulatory experts and consultants from across the sector: Romuald Braun of uanotau; Peter Brandstetter of IBM’s GBS Life Sciences team; Torben Thorhauge of NNIT; and Steve Gens of Gens Associates. The audience, made up of AMPLEXOR customers, also participated in the debate.

Read more